Publicacions en què col·labora amb Angel Celdrán Uriarte (5)

2019

  1. Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients

    Pathology and Oncology Research, Vol. 25, Núm. 1, pp. 269-278

2017

  1. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma

    Pathology and Oncology Research, Vol. 22, Núm. 2, pp. 377-383

2015

  1. Identification of Poor-outcome Biliopancreatic Carcinoma Patients with Two-marker Signature Based on ATF6α and p-p38 "sTARD Compliant"

    Medicine (United States), Vol. 94, Núm. 45, pp. e1972

2012

  1. Prognostic utility of tumor thickness at the tumor-normal interface in chemotherapy-treated hepatic colorectal metastasis

    Pathology Research and Practice, Vol. 208, Núm. 4, pp. 235-239